Patient-Centered Tablets: Applications for Inpatient Admissions

Not Applicable

Completed

• Conditions: Mobile Health
• Interventions: Other: Extensive bedside training for accessing patient portal; Other: Limited bedside training on patient portal use.

• Registration Number: NCT02109601
• Lead Sponsor: University of California, San Francisco

Brief Summary

RESEARCH QUESTION:

Are hospitalized patients able to use a tablet computer (iPad) to take brief surveys, access their patient portal (MyChart), and watch informational videos about their condition?

Detailed Description

STUDY DESIGN:

Small pilot study evaluating pre/post impressions of information technology and the feasibility of using a tablet computer for education purposes and to complete a daily survey about preparations for discharge and post-acute care.

The study has two distinct parts. Patients will have the option to participate in either one or both parts.

PART 1: Using iPads to learn about health conditions We will enroll and randomize patients to intervention or control groups. Allocation to be intervention or control group will be determined using a computer-based random number generator. All patients will be orientated to using an iPad, asked to take a pre-use survey, will have a MyChart account set up and view EMMI modules. Intervention group patients will receive specific detailed education about how to access, navigate and use MyChart using tablets (iPads) . Control group patients will not receive this specific education about how to access, navigate and use MyChart using tablets (iPads). Both intervention and control group patients will be asked to complete a post-use survey. We will access MyChart data repositories to determine if patients continue to access their patient portal for up to 30 days after the completion of this part of the study.

PART 2: Using iPads to prepare for discharge We will enrol all eligible patients (regardless of intervention or control group status in Part 1) to complete a daily Readiness for Discharge Survey (RDS). This standardized validated survey will determine a range of discharge and post-acute issues and will be fed back to the patient's health care team. Patient demographic and clinical information will be abstracted from their medical record to determine if there are any specific issues related to specific groups of patients. Initially the RDS will be completed on a paper survey but will be eventually be administered via an iPad.

Study Timeline

• Study Start: 2013-11
• Study First Submitted: 2014-04-03
• Study First Submitted QC: 2014-04-07
• Study First Posted: 2014-04-10
• Primary Completion: 2014-11
• Study Completion: 2015-02
• Status Verified: 2020-02
• Last Update Submitted: 2020-02-05
• Last Update Posted: 2020-02-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

Adult patients admitted to any service at UCSF Medical Center

Read More

Exclusion Criteria

Patients not speaking English. Patients unable to give consent. Patients unable to safely use a tablet computer for any reason. Patients being discharged on day of approach. Patient cognitively impaired and unable to give consent. Patient in ICU. Patient in some form of droplet isolation.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	Extensive bedside training for accessing patient portal	Intervention patient receive iPad tablets during their hospital stay with EXTENSIVE bedside training from a research assistant on how to access and effectively use their patient portal.
Control	Limited bedside training on patient portal use.	Control patients receive iPad tablets during their hospital stay with only LIMITED bedside training from a research assistant on how to access and effectively use their patient portal.

Primary Outcome Measures

Name	Time	Method
Patient Portal Usage	During and after hospitalization (up to 30 days)	Effects of iPad intervention to improve patient access to their patient portal will be assessed during hospitalization and for 30 days after discharge.

Trial Locations

Locations (1)

University of California San Francisco Medical Center (Moffitt-Long Hospital); 🇺🇸 San Francisco, California, United States